Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating safety and tolerability of brexucabtagene autoleucel (KTE-X19) in relapsed/refractory chronic lymphocytic leukemia …
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 trial of acalabrutinib (ACP-196) in combination with pembrolizumab in hematologic malignancies has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL [Phase 2]
Phase 2 trial update evaluating orelabrutinib with obinutuzumab plus FC in newly diagnosed CLL/SLL.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial investigating bendamustine and rituximab in combination with copanlisib for chronic lymphocytic leukemia or small lymphocytic …
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL [Phase 1, Phase 2]
Phase 1/2a dose-escalation study in CLL/SLL and various NHL subtypes completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL [Phase 2]
Phase 2 trial evaluating zanubrutinib followed by zanubrutinib plus FCR/BR in newly diagnosed symptomatic CLL/SLL.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 3]
This Phase 3 clinical trial update reports results for frontline therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma comparin…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 3]
Phase 3 trial evaluating ibrutinib plus venetoclax versus chlorambucil plus obinutuzumab as first-line therapy in chronic lymphocytic leukem…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]
Phase 2 study evaluating the combination of ibrutinib and venetoclax in treatment-naive chronic lymphocytic leukemia/small lymphocytic lymph…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I) [Phase 2]
Phase 2 trial assessing SHINGRIX vaccine response in chronic lymphocytic leukemia patients, including those treated with BTK inhibitors; stu…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL [Phase 2]
Phase 2 trial evaluating consolidative therapy with ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating lenalidomide in combination with rituximab for various stage III/IV indolent non-Hodgkin lymphoma subtypes; study c…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL [Phase 2]
Phase 2 trial evaluating venetoclax plus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic ly…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1, Phase 2]
Phase 1/2 open-label dose-finding trial evaluating CC-122 in combination with ibrutinib and obinutuzumab for chronic lymphocytic leukemia/sm…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL [Phase 2]
Phase 2 trial evaluating acalabrutinib in patients with relapsed/refractory and treatment-naïve deletion 17p chronic lymphocytic leukemia/sm…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Study Evaluating Venetoclax in Subjects With Hematological Malignancies [Phase 1, Phase 2]
Clinical trial update for venetoclax in hematological malignancies at phases 1 and 2; study status completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell [Phase 1]
Phase 1 study updating on CAR-20/19-T cells in relapsed/refractory B-cell lymphomas; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating ruxolitinib phosphate in previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma has completed…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial in Japanese participants assessing safety, tolerability, and pharmacokinetics of idelalisib in relapsed or refractory indolent…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL [Phase 1, Phase 2]
Phase 1/2 study of TP-0903 (AXL inhibitor) in previously treated chronic lymphocytic leukemia was terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis [Phase 2]
Phase 2 trial evaluating lenalidomide to enhance immune response to vaccine therapy in patients with chronic lymphocytic leukemia, small lym…
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]
Phase 2 trial evaluating Ofatumumab in combination with methylprednisolone or with lenalidomide in relapsed/refractory CLL/SLL has completed…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL [Phase 2]
Phase II clinical trial evaluating the combination of ibrutinib and short-course fludarabine in treatment-naive chronic lymphocytic leukemia…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of zanubrutinib in relapsed or refractory chronic lymphocytic leukemia and small lymphocy…
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 safety and tolerability study of PCI-32765 in various B-cell malignancies completed; results posted.